Abstract
Pancreatic cancer ranks as the fourth cause of cancer-associated deaths in the West. It is an aggressive cancer with poor prognosis and a huge mortality rate. Current treatment modalities used for treating PC (surgery and chemoradiotherapy) have limited outcomes due to stroma-induced chemoresistance. These shortcomings stress the need for new therapeutic solutions with increased efficacy and cytotoxicity for PC. In recent years, nanotechnology has emerged as a promising solution for improving diagnosis, drug delivery, and treatment in many cancers including PC. In this chapter, we explore the various nanotechnologies developed to date, their chemical composition, pharmacological properties, and activity. We also discuss their potential as drug delivery solutions for PC.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Breaking Tolerance to Pancreatic Cancer Unresponsiveness to Chemotherapy
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
